Top Markets
Coin of the day
NutraLife BioSciences, Inc. NutraLife BioSciences, Inc.

NutraLife BioSciences, Inc.

NLBS
Kedudukan dalam Saham #41573
NutraLife BioSciences, Inc., operating with its subsidiaries, specializes in... NutraLife BioSciences, Inc., operating with its subsidiaries, specializes in the creation, production, and distribution of a diverse range of health-oriented products. This includes nutraceuticals, dietary supplements, general wellness items, and a significant line of cannabidiol (CBD) products. The company's CBD portfolio is comprehensive, featuring cannabinoid-rich hemp oil sourced from industrial hemp, tinctures, and a variety of topical solutions like lotions and oils designed for direct skin application to alleviate pain or inflammation. Their CBD offerings also extend to face creams, massage oils, nutraceutical sprays enhanced with CBD, and specialized products for pets. In addition to its CBD range, NutraLife BioSciences also manufactures skincare items and hand sanitizers. Customers can acquire the company's products directly from its website, nutralifebiosciences.com, or through a network of private label distributors, other online retailers, and traditional brick-and-mortar stores. Established in 2010 and based in Coconut Creek, Florida, the enterprise was previously known as NutraFuels, Inc. It officially adopted its current name, NutraLife BioSciences, Inc., in March 2019.
Harga Saham
$0.0001
Disegerakkan terakhir: 2024-12-11
Modal Pasaran
$16.04K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan NutraLife BioSciences, Inc. (NLBS)

Kategori

Nisbah P/B bagi NutraLife BioSciences, Inc. (NLBS)
Nisbah P/B pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini NutraLife BioSciences, Inc., nisbah P/B semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/B syarikat ialah 0.
Sejarah nisbah P/B untuk NutraLife BioSciences, Inc. dari 2026 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/B untuk syarikat atau pesaing yang serupa